Erratum: Expression of Concern to: Does ovary need D-chiro-inositol (Journal of Ovarian Research (2012) 5 (14) DOI: 10.1186/1757-2215-5-14);Does ovary need D-chiro-inositol?

Journal of Ovarian Research

Volumn 5, Issue 1, 2012, Pages

  Isabella, Rosalbino ^a   Raffone, Emanuela ^b  

^a CIS Reproductive Medicine   (Italy)

^b G Martino Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; DEXTRO CHIRO INOSITOL; ESTRADIOL; INOSITOL; INSULIN SENSITIZING AGENT; PLACEBO; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; HYPERANDROGENISM; HYPERGLYCEMIA; INFERTILITY; INSULIN RESISTANCE; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECOND MESSENGER; TREATMENT RESPONSE;

EID: 84860902787     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/s13048-018-0431-y     Document Type: Erratum

References (33)

1. Polycystic ovary syndrome. Taylor AE, Endocrinol Metab Clin North Am 1998 27 877 902 ix 10.1016/S0889-8529(05)70045-1 9922912 (Pubitemid 28564062)
2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004 81 19 25 15126094
3. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004 19 41 47 14688154
4. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. Burghen GA, Givens JR, Kitabchi AE, J Clin Endocrinol Metab 1980 50 113 116 10.1210/jcem-50-1-113 7350174 (Pubitemid 10203585)
5. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Baillargeon JP, Carpentier A, Fertil Steril 2007 88 886 893 10.1016/j.fertnstert.2006.12.055 17559844 (Pubitemid 47498387)
6. Insulin and hyperandrogenism in women with polycystic ovary syndrome. Baptiste CG, Battista MC, Trottier A, Baillargeon JP, J Steroid Biochem Mol Biol 2010 122 42 52 10.1016/j.jsbmb.2009.12.010 20036327
7. Insulin-lowering therapeutic modalities for polycystic ovary syndrome. Ehrmann DA, Endocrinol Metab Clin North Am 1999 28 423 438 viii 10.1016/S0889-8529(05)70078-5 10352927 (Pubitemid 29242722)
8. Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome. Hasegawa I, Murakawa H, Suzuki M, Yamamoto Y, Kurabayashi T, Tanaka K, Fertil Steril 1999 71 323 327 10.1016/S0015-0282(98)00454-3 9988406 (Pubitemid 29069912)
9. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G, N Engl J Med 1999 340 1314 1320 10.1056/NEJM199904293401703 10219066 (Pubitemid 29196593)
10. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Gerli S, Mignosa M, Di Renzo GC, Eur Rev Med Pharmacol Sci 2003 7 151 159 15206484 (Pubitemid 38659930)
11. Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial. Ng EH, Wat NM, Ho PC, Hum Reprod 2001 16 1625 1631 10.1093/humrep/16.8.1625 11473953 (Pubitemid 32768540)
12. Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Huang LC, Fonteles MC, Houston DB, Zhang C, Larner J, Endocrinology 1993 132 652 657 10.1210/en.132.2.652 8425485 (Pubitemid 23056122)
13. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Papaleo E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C, Marelli G, Cino I, Redaelli A, Ferrari A, Gynecol Endocrinol 2007 23 700 703 10.1080/09513590701672405 17952759 (Pubitemid 350261211)
14. D-chiro-inositol-its functional role in insulin action and its deficit in insulin resistance. Larner J, Int J Exp Diabetes Res 2002 3 47 60 10.1080/15604280212528 11900279 (Pubitemid 35174544)
15. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Chiu TT, Rogers MS, Law EL, Briton-Jones CM, Cheung LP, Haines CJ, Hum Reprod 2002 17 1591 1596 10.1093/humrep/17.6.1591 12042283 (Pubitemid 34661813)
16. Contribution of myo-inositol to reproduction. Papaleo E, Unfer V, Baillargeon JP, Chiu TT, Eur J Obstet Gynecol Reprod Biol 2009 147 120 123 10.1016/j.ejogrb.2009.09.008 19800728
17. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, De Santis L, Fertil Steril 2009 91 1750 1754 10.1016/j.fertnstert.2008.01.088 18462730
18. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Raffone E, Rizzo P, Benedetto V, Gynecol Endocrinol 2010 26 275 280 10.3109/09513590903366996 20222840
19. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S, Eur Rev Med Pharmacol Sci 2011 15 452 457 21608442
20. Clinical outcome of oocyte cryopreservation after slow cooling with a protocol utilizing a high sucrose concentration. Borini A, Sciajno R, Bianchi V, Sereni E, Flamigni C, Coticchio G, Hum Reprod 2006 21 512 517 16239316 (Pubitemid 43159930)
21. Effects of different hyaluronidase concentrations and mechanical procedures for cumulus cell removal on the outcome of intracytoplasmic sperm injection. Van de Velde H, Nagy ZP, Joris H, De Vos A, Van Steirteghem AC, Hum Reprod 1997 12 2246 2250 10.1093/humrep/12.10.2246 9402289 (Pubitemid 27494037)
22. Oocyte cryopreservation: clinical outcome of slow-cooling protocols differing in sucrose concentration. De Santis L, Cino I, Rabellotti E, Papaleo E, Calzi F, Fusi FM, Brigante C, Ferrari A, Reprod Biomed Online 2007 14 57 63 10.1016/S1472-6483(10)60764-X 17207332 (Pubitemid 46156564)
23. Oocyte quality reflected by follicular fluid analysis in poly cystic ovary syndrome (PCOS): A hypothesis based on intermediates of energy metabolism. Arya BK, Haq AU, Chaudhury K, Med Hypotheses 2012 78 475 478 10.1016/j.mehy.2012.01.009 22336088
24. Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome. Ma X, Fan L, Meng Y, Hou Z, Mao YD, Wang W, Ding W, Liu JY, Mol Hum Reprod 2007 13 527 535 10.1093/molehr/gam036 17557764 (Pubitemid 47241906)
25. Urinary myo-inositol-to-chiro-inositol ratios and insulin resistance. Larner J, Craig JW, Diabetes Care 1996 19 76 78 8720541 (Pubitemid 26006622)
26. chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Asplin I, Galasko G, Larner J, Proc Natl Acad Sci U S A 1993 90 5924 5928 10.1073/pnas.90.13.5924 8392181 (Pubitemid 23191426)
27. Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth. Harwood K, Vuguin P, DiMartino-Nardi J, Horm Res 2007 68 209 217 17426408 (Pubitemid 47525222)
28. Polycystic ovary syndrome: etiology and pathogenesis. Matalliotakis I, Kourtis A, Koukoura O, Panidis D, Arch Gynecol Obstet 2006 274 187 197 10.1007/s00404-006-0171-x 16685527 (Pubitemid 43962162)
29. The D-chiro-inositol paradox in the ovary. Carlomagno G, Unfer V, Roseff S, Fertil Steril 2011 95 2515 2516 10.1016/j.fertnstert.2011.05.027 21641593
30. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F, Eur Rev Med Pharmacol Sci 2011 15 509 514 21744744
31. Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Cheang KI, Baillargeon JP, Essah PA, Ostlund RE, Apridonize T, Islam L, Nestler JE, Metabolism 2008 57 1390 1397 10.1016/j.metabol.2008.05.008 18803944
32. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial. Palomba S, Falbo A, Di Cello A, Cappiello F, Tolino A, Zullo F, Fertil Steril 2011 96 1128 1133 10.1016/j.fertnstert.2011.08.020 21917254
33. Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome. Baillargeon JP, Iuorno MJ, Jakubowicz DJ, Apridonidze T, He N, Nestler JE, J Clin Endocrinol Metab 2004 89 242 249 10.1210/jc.2003-030437 14715857 (Pubitemid 38183889)